Skip to content

Quality of Life Assessment of Caregivers of Patients With Multiple Myeloma

Quality of Life Assessment of Caregivers of Patients With Multiple Myeloma Participating in a Therapeutic Education Program and Receiving a Supportive Care Needs Evaluation

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07276230
Acronym
ENTRAIDANT
Enrollment
27
Registered
2025-12-10
Start date
2026-02-01
Completion date
2027-11-01
Last updated
2025-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregivers of Patients With Multiple Myeloma

Keywords

caregivers, multiple myeloma

Brief summary

The diagnosis and treatment of multiple myeloma affect not only the patient but also their family and caregivers. Advances in therapy have transformed the follow-up of patients treated for multiple myeloma. The involvement of informal caregivers has become increasingly essential to ensure adequate home-based care, as most treatments are now delivered on an outpatient basis. Literature reviews suggest that caregivers of cancer patients often face unmet supportive care needs, which in turn negatively impact their quality of life.

Detailed description

By improving the quality of life of caregivers, the intervention can help prevent cascading effects such as a deterioration in the quality of life of the care recipient, thereby reducing the overall burden on healthcare systems. In addition, therapeutic education is an ongoing process aimed at helping patients and/or caregivers acquire or maintain the skills they need to best manage their lives with a chronic condition. Study procedures : 1. During the hematology consultation, the study will be presented to the caregiver identified by the patient (between Day -7 and Day 0). After receiving full oral and written information, the caregiver's free, written, and informed consent will be obtained prior to participation. 2. After providing written informed consent to participate in the study, the caregiver will attend an individual interview at Day 0 with a nurse to complete a Shared Educational Assessment .The caregiver will then independently complete a self-administered questionnaire assessing quality of life using the CarGOQoL (CareGiver Oncology Quality of Life). The Shared Educational Assessment is a discussion between the healthcare professional and the caregiver focusing on the skills to be acquired or strengthened in order to improve health and quality of life. It enables exploration and assessment of the caregiver's needs and resources in terms of : * Acquisition of knowledge; * Acquisition or reinforcement of self-care and coping skills, while recognizing and valuing the caregiver's own self learning efforts. 3. The group of caregivers thus constituted will attend four therapeutic education workshops. Each workshop will last approximately 1 hour and 30 minutes. Caregivers will attend two half-day sessions, participating in two workshops per session (Week 1: Workshops 1 & 2; Week 2: Workshops 3 & 4). The topics addressed in the workshops are as follows: * Workshop 1: Understanding the disease * Workshop 2: Identifying abnormalities in biological tests and adapting the appropriate response * Workshop 3: Understanding treatments and their adverse effects * Workshop 4: Expressing personal experiences and feelings caregivers' satisfaction with each workshop will be assessed at the end of every session 4. At the end of the program (three months after inclusion), the caregiver will attend a follow-up consultation with the nurse to evaluate skill acquisition and will independently complete the same quality of life questionnaire (CarGOQoL) that was administered prior to the program 5. At six months, a new assessment of quality of life will be conducted using the CarGOQoL questionnaire during a telephone interview with a member of the investigative team The questionnaire will be available in paper format, and the responses will be entered into an electronic case report form (e-CRF) using the CleanWeb system. The data will be analyzed by the Clinical Research Unit (URC).

Interventions

OTHERTherapeutic Education and Needs Assessment Program for Caregivers

Participation in a weekly therapeutic education group for 4 weeks.

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Caregivers of patients followed for multiple myeloma during first-line therapy

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Caregiver : * Designated by a patient followed for multiple myeloma during first-line treatment * Providing weekly assistance to the patient (e.g., shopping, housekeeping, management of daily living activities, healthcare or hygiene support, etc.) * Aged 18 years or older * Fluent in French * Affiliated with or benefiting from a social security system (excluding state medical aid - AME) * Able to provide free, written, and informed consent

Exclusion criteria

Caregiver : * Not designated by the patient as the primary caregiver * Currently being treated for an acute medical condition * Refusal of the caregiver to participate in the study * Under legal protection (guardianship or curatorship)

Design outcomes

Primary

MeasureTime frameDescription
Effectiveness of a needs assessment approach through participation in a therapeutic education program on improving the quality of life of caregivers of patients with multiple myeloma.3 monthsChange in caregivers' CarGOQoL (CareGiver Oncology Quality of Life) scores between baseline and 3 months. The higher the score, the better the quality of life.

Secondary

MeasureTime frameDescription
Caregivers' adherence to the therapeutic education program for caregivers of patients with multiple myeloma3 monthsProportion of caregivers who completed the entire therapeutic education program
Changes in caregivers' specific skills after participation in the program (self-care and coping skills)6 monthsAssessment of self-care and coping skills using a four-level competency acquisition scale: acquired, not acquired, introduced, and reinforcement session required
Caregivers' satisfaction with participation in the workshops2 weeksCaregivers' satisfaction measured using a Visual Analogue Scale (VAS) ranging from 1 to 10. The higher the score, the greater the satisfaction.
The long-term effectiveness of this approach on caregivers' quality of life.6 monthsChange in caregivers' CarGOQoL (CareGiver Oncology Quality of Life) scores between baseline and 6 months. The higher the score, the better the quality of life.

Countries

France

Contacts

Primary ContactAnne LE BORGNE, Mrs
anne.le-borgne@aphp.fr01 84 82 83 15
Backup ContactLaurent Dr GARDERET, MD
laurent.garderet@aphp.fr01 42 16 27 94

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026